|
July. 29, 2019 |
|
|
July. 31, 2019 |
|
|
jRCT2080224808 |
Phase 1 trial of adrenomedullin; Single-dose administration study |
|
Single-dose administration study of adrenomedullin |
University of Miyazaki |
||
5200 Kihara, Kiyotake, Miyazaki, JAPAN |
||
+81-985-85-0872 |
||
University of Miyazaki |
||
5200 Kihara, Kiyotake, Miyazaki, JAPAN |
||
+81-985-85-0872 |
||
completed |
Nov. 12, 2015 |
||
| 24 | ||
Interventional |
||
randomized, double-blind, single-center, dose-escalation study |
||
treatment purpose |
||
1 |
||
healthy male |
||
history of malignancy and/or myocardial infarction |
||
| 20age old over | ||
| 65age old under | ||
Male |
||
healthy |
||
investigational material(s) |
||
safety |
||
pharmacokinetics |
||
| University of Miyazaki | |
| Souseikai Hakata Clinic |
| Japan Agency for Medical Research and Development | |
| Practical Research Project for Rare/Intractable Diseases |
| Institutional Review Board of University of Miyazaki | |
| 5200 Kihara, Kiyotake, Miyazaki, JAPAN | |
+81-985-85-9852 |
|
| approved | |
May. 28, 2015 |
| JapicCTI-194891 | |
| Japan |